{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains how mitochondrial dysfunction leads to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the role of mitochondrial dysfunction in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assays are suitable for evaluating mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are appropriate for this context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were used in the study.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicate experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Sufficient statistical analyses were performed.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses, including enzyme activity assays and replication controls, were sufficient."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant demonstrates strong functional evidence supporting its pathogenic role in Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "H",
          "alt": "R",
          "position": "117"
        },
        "variant_string_id": "CFTR R117H"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses mitochondrial dysfunction and its relation to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The paper explains how mitochondrial dysfunction contributes to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assays are suitable for evaluating mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are appropriate for this context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were used in the study.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicate experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Sufficient statistical analyses were performed.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses, including enzyme activity assays and replication controls, were sufficient."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant demonstrates strong functional evidence supporting its pathogenic role in Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "K",
          "alt": "D"
        },
        "variant_string_id": "PINK1 H105K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains mitochondrial dysfunction and its relation to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The paper clarifies how mitochondrial dysfunction contributes to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assays are suitable for evaluating mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are appropriate for this context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were used in the study.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicate experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Sufficient statistical analyses were performed.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses, including enzyme activity assays and replication controls, were sufficient."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant demonstrates strong functional evidence supporting its pathogenic role in Parkinson's disease."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L"
        },
        "variant_string_id": "DJ-1 L236K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains mitochondrial dysfunction and its relation to Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The paper clarifies how mitochondrial dysfunction contributes to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Enzyme activity assays are suitable for evaluating mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are appropriate for this context."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls and replicates were used in the study.",
          "judgment": "Yes",
          "reasoning": "The paper includes basic controls and replicate experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Sufficient statistical analyses were performed.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses, including enzyme activity assays and replication controls, were sufficient."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "This variant demonstrates strong functional evidence supporting its pathogenic role in Parkinson's disease."
    }
  ]
}